![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
Stroke prevention |
Hepatitis |
Free Subscription
2 Am J Gastroenterol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Hepatitis is free of charge.
Withdrawal of long-term nucleotide analogue therapy in chronic hepatitis B:
Outcomes from the withdrawal phase of the HBRN immune active treatment trial.
Am J Gastroenterol. 2023 Jan 13. doi: 10.14309/ajg.0000000000002176.
PubMed
Abstract available
Incidence of hepatic decompensation after nucleos(t)ide analogue withdrawal:
Results from a large, international, multi-ethnic cohort of patients with chronic
hepatitis B (RETRACT-B study).
Am J Gastroenterol. 2023 Jan 30. doi: 10.14309/ajg.0000000000002203.
PubMed
Abstract available
Liver Injury Associated with Turmeric-A Growing Problem: Ten Cases from the
Drug-Induced Liver Injury Network [DILIN].
Am J Med. 2023;136:200-206.
PubMed
Abstract available
COVID-19 Pandemic Associated Declines and Subsequent Increases in Hepatitis C
Virus Treatment Prescriptions in Los Angeles County.
Clin Infect Dis. 2023 Jan 31:ciad050. doi: 10.1093.
PubMed
Recurrence of hepatocellular carcinoma in noncirrhotic patients with nonalcoholic
fatty liver disease versus hepatitis B infection.
Eur J Gastroenterol Hepatol. 2022 Dec 23. doi: 10.1097/MEG.0000000000002504.
PubMed
Abstract available
The nationwide trends in hospital admissions, deaths, and costs related to
hepatitis C stratified by psychiatric disorders and substance use: an analysis of
US hospitals between 2016 and 2019.
Eur J Gastroenterol Hepatol. 2022 Dec 23. doi: 10.1097/MEG.0000000000002498.
PubMed
Abstract available
What does quantitative HBsAg level mean in chronic hepatitis D infection?
Eur J Gastroenterol Hepatol. 2023;35:320-326.
PubMed
Abstract available
Positive hepatitis B core antibody is associated with advanced fibrosis and
mortality in nonalcoholic fatty liver disease.
Eur J Gastroenterol Hepatol. 2023;35:294-301.
PubMed
Abstract available
Predictive models for hepatocellular carcinoma development after sustained
virological response in advanced hepatitis C.
Gastroenterol Hepatol. 2023 Jan 27:S0210-5705(23)00013.
PubMed
Abstract available
Phenotypic CD8 T cell profiling in chronic hepatitis B to predict HBV-specific
CD8 T cell susceptibility to functional restoration in vitro.
Gut. 2023 Jan 30:gutjnl-2022-327202. doi: 10.1136/gutjnl-2022-327202.
PubMed
Abstract available
Quantification of the hepatitis B virus cccDNA: evidence-based guidelines for
monitoring the key obstacle of HBV cure.
Gut. 2023 Jan 27:gutjnl-2022-328380. doi: 10.1136/gutjnl-2022-328380.
PubMed
Abstract available
Cracking the host functional network involved in hepatitis B virus cccDNA
biology.
Gut. 2023 Jan 27:gutjnl-2022-329185. doi: 10.1136/gutjnl-2022-329185.
PubMed
Letter to the editor: Successful treatment of multidrug-resistant hepatis C after
>12 months of continuous therapy with direct-acting antivirals.
Hepatology. 2023;77:E26-E27.
PubMed
Non-selective Beta Blockers, Hepatic Decompensation and Mortality in Cirrhosis: A
National Cohort Study.
Hepatology. 2022 Aug 19. doi: 10.1002/hep.32737.
PubMed
Abstract available
HBV transcription and translation persist despite viral suppression in HBV-HIV
co-infected patients on antiretroviral therapy.
Hepatology. 2023;77:594-605.
PubMed
Abstract available
Patients With Autoimmune Hepatitis and Nonalcoholic Fatty Liver Disease:
Characteristics, Treatment, and Outcomes.
J Clin Gastroenterol. 2022 Dec 20. doi: 10.1097/MCG.0000000000001817.
PubMed
Abstract available
Eliminating cccDNA to cure Hepatitis B virus (HBV) infection.
J Hepatol. 2023 Jan 27:S0168-8278(23)00029-6. doi: 10.1016/j.jhep.2023.
PubMed
Long-term outcomes of patients with type 1 or 2 autoimmune hepatitis presenting
in childhood.
J Hepatol. 2023 Jan 25:S0168-8278(23)00025-9. doi: 10.1016/j.jhep.2023.
PubMed
Abstract available
Sustained virological response in an HCV-infected patient on an enzyme-inducing
anti-epileptic agent despite undetectable trough plasma levels of velpatasvir.
J Hepatol. 2023 Jan 25:S0168-8278(23)00027-2. doi: 10.1016/j.jhep.2023.
PubMed
Second-phase hepatitis C plasma viral kinetics directly reflects reduced
intrahepatic burden of HCV.
J Infect Dis. 2023 Feb 1:jiad025. doi: 10.1093.
PubMed
Abstract available
Now is the Time to Scale Up Birth Dose Hepatitis Vaccine in Low and Middle-Income
Countries.
J Infect Dis. 2023 Jan 31:jiad026. doi: 10.1093.
PubMed
HBsAg (-)/HBsAb (-)/HBeAg (-)/HBeAb (+)/HBcAb (+) predicts a high risk of
hepatitis B reactivation in patients with B-cell lymphoma receiving rituximab
based immunochemotherapy.
J Med Virol. 2023 Feb 3. doi: 10.1002/jmv.28549.
PubMed
Abstract available
Usefulness of dried blood spot samples for monitoring hepatitis C treatment
outcome and reinfection among people who inject drugs in a test-and-treat
program.
J Med Virol. 2023 Feb 2. doi: 10.1002/jmv.28544.
PubMed
Abstract available
Drug Screening for Hepatitis A Virus (HAV): Nicotinamide Inhibits c-Jun
Expression and HAV Replication.
J Virol. 2023 Feb 2:e0198722. doi: 10.1128/jvi.01987.
PubMed
Abstract available
Biographical Feature: Marc S. Collett (23 May 1951-11 June 2022): the Battle
against Viral Disease Has Lost a Valiant Warrior, and the World Has Lost a
Splendid Human Being.
J Virol. 2023;97:e0164322.
PubMed
Sero-prevalence of hepatitis B virus and compliance with hepatitis B vaccination
schedules among outpatient clinic attendees in Nairobi.
PLoS One. 2023;18:e0281256.
PubMed
Abstract available
Safety and effectiveness of 8 weeks of Glecaprevir/Pibrentasvir in challenging
HCV patients: Italian data from the CREST study.
PLoS One. 2023;18:e0280165.
PubMed
Abstract available
Disease burden among migrants in Morocco in 2021: A cross‑sectional study.
PLoS One. 2023;18:e0281129.
PubMed
Abstract available
Impact of HCV Treatment on Recurrence of Hepatocarcinoma After Liver
Transplantation.
Transplant Proc. 2023 Jan 25:S0041-1345(22)00884.
PubMed
Abstract available
Rift Valley Fever vaccine strategies: Enhanced stability of RVF Clone 13.
Vaccine. 2022 Dec 31:S0264-410X(22)01591-2. doi: 10.1016/j.vaccine.2022.
PubMed
Abstract available
Thank you for your interest in scientific medicine.
This policy is made possible thanks to
a media sponsorship by